levodopa

FDA Drug Profile — Inbrija

levodopa is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand name including Inbrija. Available dosage forms: capsule, powder.

Drug Details

Generic Name
levodopa
Brand Names
Inbrija
Application Number
NDA209184
Sponsor
Catalent Pharma Solutions, LLC
NDC Codes
6
Dosage Forms
CAPSULE, POWDER
Routes
RESPIRATORY (INHALATION)
Active Ingredients
LEVODOPA

Indications and Usage

1 INDICATIONS AND USAGE VYALEV is indicated for the treatment of motor fluctuations in adults with advanced Parkinson’s disease (PD). VYALEV is a combination of foscarbidopa (an aromatic amino acid decarboxylation inhibitor) and foslevodopa (an aromatic amino acid) indicated for the treatment of motor fluctuations in adults with advanced Parkinson’s disease. ( 1 )